Pulse Biosciences, Inc.
PLSE
$16.56
-$0.4899-2.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 31.47M | 27.78M | 23.92M | 19.06M | 16.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.24M | 63.69M | 56.26M | 48.53M | 46.13M |
| Operating Income | -72.24M | -63.69M | -56.26M | -48.53M | -46.13M |
| Income Before Tax | -68.03M | -60.24M | -53.59M | -46.13M | -44.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -68.03 | -60.24 | -53.59 | -46.13 | -44.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -68.03M | -60.24M | -53.59M | -46.13M | -44.02M |
| EBIT | -72.24M | -63.69M | -56.26M | -48.53M | -46.13M |
| EBITDA | -71.10M | -62.52M | -55.08M | -47.33M | -44.93M |
| EPS Basic | -1.06 | -0.97 | -0.90 | -0.80 | -0.78 |
| Normalized Basic EPS | -0.66 | -0.61 | -0.56 | -0.50 | -0.49 |
| EPS Diluted | -1.06 | -0.97 | -0.90 | -0.80 | -0.78 |
| Normalized Diluted EPS | -0.66 | -0.61 | -0.56 | -0.50 | -0.49 |
| Average Basic Shares Outstanding | 257.52M | 247.43M | 237.43M | 230.43M | 226.23M |
| Average Diluted Shares Outstanding | 257.52M | 247.43M | 237.43M | 230.43M | 226.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |